Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04253561
Title Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients (IPATHER)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors SOLTI Breast Cancer Research Group
Indications

Her2-receptor positive breast cancer

Therapies

Ipatasertib + Pertuzumab + Trastuzumab

Age Groups: adult | senior
Covered Countries ESP

Additional content available in CKB BOOST